China : will international investors reconsider their exposure?

By Peter Garnry, Head of Equity Strategy at Saxo

Chinese equities were significantly lower following the country's leadership shuffle over the weekend as investors are increasingly readjusting lower their views on longer term growth in private sector profits. Chinese equities are selling at a historical discount to US equities in a sign of a rising equity risk premium on Chinese equities. This rising equity risk premium comes also with risk for the US equity market as many US companies have large revenue exposure to China.

There are bad days in the equity market when everything is on sale with liquidity effects driving all stocks over the cliff, and then there are days when an isolated equity market plunges even when most other equity markets are on the rise. The latter happened in Monday’s trading session when the Hang Seng Index declined by 6% and the CSI 300 (mainland Chinese index) fell 3% as investors decided to sell first and ask questions later upon witnessing the shuffle in Chinese leadership presented over the weekend.

The weekend’s events in China are arguably the culmination of a long journey, in which China has been placing ever more emphasis on the importance of the public sector over the private sector, as encapsulated in the Chinese policy of “Common Prosperity”. The price action in Chinese equities speaks volumes when we see the tumbling Hang Seng Price Index trading at levels not seen since the global financial crisis in 2009, even if the total return index is less gloomy and only at a level last seen in 2013. More importantly, the spread in equity valuation between the Hang Seng Composite Index and S&P 500 has dropped to very low levels (60% below S&P 500) with the Hang Seng Composite Index now valued at a mere 6.8 times earnings.

The rising Chinese equity risk premium

The valuation differential reflects the growing political risk premium and lower confidence in those underlying Chinese earnings as Common Prosperity is likely a drag on private sector earnings growth longer term. At times in recent years, Chinese technology companies often traded at higher equity valuations than their Silicon Valley peers, but since Common Prosperity was adopted, the situation has changed dramatically with lower earnings and revenue growth among Chinese technology companies, leading to massive losses for investors. We maintain an underweight view on Chinese equities as a precautionary measure. Countries such as India, Vietnam, and Indonesia are the big winners of the current realignment of global supply chains and thus considering for Asian exposure.

A growing equity risk premium on Chinese equities naturally leads to the question of whether the US equity market could suddenly be jolted by a repricing of its China exposure. Is a dollar of free cash flow in China worth the same as a dollar of free cash flow from the US or Europe? Arguably not, and while this has been reflected in the revaluation of many semiconductor companies (also partly due to the US CHIPS Act) it has not been fully reflected in more consumer-oriented stocks like Apple and Tesla. With around 20% of its revenue coming from China, Apple’s risk profile could be rising on the risk of a sudden repricing due of a Chinese equity risk premium. Tesla gets 25% of its revenue in China and thus also has significant China exposure that is currently not reflected in its equity valuation. Apple and Tesla shares are key for broader equity sentiment and any downside risk dynamics in these two stocks could quickly jeopardize the wider equity market.

Investor flows into Chinese equities and companies with high China exposure

While price action tells one story on China, investor flows in ETFs tracking MSCI China A shares are telling a slightly different story. The number of outstanding shares (essentially how much capital that is deployed in an underlying index) has been growing steadily over the years as China’s capital markets have opened up. The has led to more inclusion in EM- and global benchmark indices of equities and bonds. While we have seen significant outflows out of ETFs tracking CNY bonds, until very recently at least, we have observed the opposite in Chinese equities. Falling equity prices in China have prompted rising investor flows into a “China is cheap” narrative. But sometimes, things are cheap for a reason (the equity risk premium discussion above). Over the last couple of months, this trend has shifted: in August, the largest UCITS ETF, which tracks MSCI China A shares, has begun seeing declining outstanding shares. As of Friday the current drawdown was -12%. This could be an early sign that investor appetite is on the decline.

MSCI, the leading global equity index provider, has created an index called the MSCI World with China Exposure Index (USD). It covers 51 companies with the greatest revenue exposure to China. This index is a good starting point for any investor who would like to break down portfolio exposure to China. The 10 largest companies in the MSCI World with China Exposure Index (USD) are listed below.

  • Qualcomm
  • BHP Group
  • Texas Instruments
  • Broadcom
  • Rio Tinto
  • Applied Materials
  • Woodside Energy
  • Lam Research
  • Fortescue Metals Group
  • Marvell Technology

As noted above, in addition to this list we would argue companies such as Apple and Tesla have considerable revenue exposure to China and thus have downside risks to their equity valuation.

Further reading : China’s risk premium on the rise; critical earnings week ahead

Peter Garnry

Press contact

Share

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.

About Saxo Bank

About Saxo

At Saxo we believe that when you invest, you unlock a new curiosity for the world around you. As a provider of multi-asset trading and investment solutions, Saxo’s purpose is to Get Curious People Invested in the World. We are committed to enabling our clients to make more of their money. Saxo was founded in Copenhagen, Denmark in 1992 with a clear vision: to make the global financial markets accessible for more people. In 1998, Saxo launched one of the first online trading platforms in Europe, providing professional-grade tools and easy access to global financial markets for anyone who wanted to invest.

Today, Saxo is an international award-winning investment firm for investors and traders who are serious about making more of their money. As a well-capitalised and profitable fintech, Saxo is a fully licensed bank under the supervision of the Danish FSA, holding broker and banking licenses in multiple jurisdictions. As one of the earliest fintechs in the world, Saxo continues to invest heavily into our technology. Saxo’s clients and partners enjoy broad access to global capital markets across asset classes on our industry-leading platforms. Our open banking technology also powers more than 150 financial institutions as partners by boosting the investment experience they can offer their clients (B2B2C). Keeping our headquarters in Copenhagen, Saxo has more than 2,300 professionals in financial centres around the world including London, Singapore, Amsterdam, Hong Kong, Zurich, Dubai and Tokyo.

For more information, please visit: www.home.saxo

 

Disclaimer

The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:

Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
Full disclaimer (https://www.home.saxo/legal/disclaimer/saxo-disclaimer)